2008, Número 3
<< Anterior Siguiente >>
Patol Rev Latinoam 2008; 46 (3)
Noticias breves
Idioma: Español
Referencias bibliográficas: 9
Paginas: 286-292
Archivo PDF: 177.70 Kb.
FRAGMENTO
Este artículo destaca la importancia del análisis morfológico para diagnósticar las enfermedades linfoproliferativas. Se evalúan, según diversos estudios recopilados, los alcances y las limitaciones de la inmunohistoquímica, citometría de flujo y biología molecular, además de la función morfológica cuando los resultados de dichos estudios son negativos, aberrantes o erróneos.
REFERENCIAS (EN ESTE ARTÍCULO)
Davey E, Barratt A, Irwig L, et al. Effect of study design and quality on unsatisfactory rates, cytology classifications, and accuracy in liquid-based versus conventional cervical cytology: a systematic review. Lancet 2006;367:122-32.
Ronco G, Cuzick J, Perotti P, et al.Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening randomised controlled trial. BMJ 2007;353:28.
Sawaya GF. Evidence-based medicine versus liquid-based cytology. Obstet Gynecol 2008;111:2-3.
Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-19.
National Cancer Institute. SEER Cancer Statistics Review 1973- 1999. Available at: http://seer.cancer. gov/csr/1973_1999/. Accessed February 15, 2008.
Wright TC Jr, Massad LS, Dunton CJ, et al. for the 2006 American Society for Colposcopy and Cervical Pathology-sponsored Consensus Conference. 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. Am J Obstet Gynecol 2007;197:340-5.
Centers for Disease Control and Prevention. Human Papillomavirus: HPV Information for Clinicians. November 2006. Available at: http:// www.cdc.gov/std/hpv-clinicians-brochure. htm. Accessed February 15, 2008.
Saslow D, Runowicz CD, Solomon D, et al. American Cancer Society guidelines for the early detection of cervical neoplasia and cancer. CA Cancer J Clin 2002;52:342-62.
Wright T, Schiffman M, Solomon D,et al. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstet Gynecol 2004;103:304-9.